Bone Biologics Corp (BBLG)
1.19
-0.10
(-7.75%)
USD |
NASDAQ |
Nov 15, 16:00
1.24
+0.05
(+4.20%)
After-Hours: 20:00
Bone Biologics Total Liabilities (Quarterly): 0.2845M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.2845M |
March 31, 2024 | 0.1646M |
December 31, 2023 | 0.8314M |
September 30, 2023 | 1.183M |
June 30, 2023 | 1.930M |
March 31, 2023 | 4.011M |
December 31, 2022 | 2.548M |
September 30, 2022 | 0.7995M |
June 30, 2022 | 0.0706M |
March 31, 2022 | 0.0549M |
December 31, 2021 | 0.0999M |
September 30, 2021 | 15.18M |
June 30, 2021 | 14.62M |
March 31, 2021 | 14.20M |
December 31, 2020 | 13.69M |
September 30, 2020 | 13.24M |
June 30, 2020 | 12.85M |
March 31, 2020 | 12.47M |
Date | Value |
---|---|
December 31, 2019 | 11.90M |
September 30, 2019 | 11.63M |
June 30, 2019 | 11.12M |
March 31, 2019 | 10.79M |
December 31, 2018 | 9.639M |
September 30, 2018 | 9.525M |
June 30, 2018 | 9.834M |
March 31, 2018 | 9.005M |
December 31, 2017 | 9.192M |
September 30, 2017 | 12.84M |
June 30, 2017 | 11.39M |
March 31, 2017 | 10.24M |
December 31, 2016 | 9.065M |
September 30, 2016 | 8.123M |
June 30, 2016 | 7.950M |
March 31, 2016 | 7.634M |
December 31, 2015 | 7.228M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0549M
Minimum
Mar 2022
15.18M
Maximum
Sep 2021
6.322M
Average
2.548M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
Johnson & Johnson | 108.13B |
Dermata Therapeutics Inc | 1.918M |
NovaBay Pharmaceuticals Inc | 2.805M |
Palatin Technologies Inc | 10.85M |
iBio Inc | 7.41M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 3.194M |
Shareholders Equity (Quarterly) | 2.909M |